Recombinant Human Bone Morphogenetic Protein-2（University Of Baghdad）

N/A

Report date: 2023/02/09 20:00:50

Base Information

Drug NameRecombinant Human Bone Morphogenetic Protein-2（University Of Baghdad）
Drug Alias NameRecombinant Human Bone Morphogenetic Protein-2 with an Absorbable Collagen Sponge（University Of Baghdad）rhBMP-2（University Of Baghdad）
ClassificationBiologics
Mechanisms of ActionBone morphogenetic protein receptor type-1A stimulantsBone morphogenetic protein receptor type-1B stimulants
TargetsBone morphogenetic protein receptor type-1ABone morphogenetic protein receptor type-1B
Therapy Area/IndicationsDiabetes MellitusHematologic DiseasesHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIraq
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Baghdad
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Baghdad
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusHematologic DiseasesHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A